Concepedia

Publication | Open Access

Phase II study of low‐dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia

DOIFull Paper Access

134

Citations

20

References

2007

Year

Yasuhiro Oki, Hagop M. Kantarjian, Vazganush Gharibyan, Dan Jones, Susan O’Brien, Srđan Verstovšek, Jörge E. Cortes, Gail Morris, Guillermo Garcia‐Manero, Jean‐Pierre J. Issa
Cancer

Abstract

Combination therapy with decitabine and imatinib is well tolerated and active in advanced phase CML without BCR-ABL kinase mutations.

References

YearCitations

Page 1